v3.26.3
Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jan. 26, 2026
Jan. 14, 2026
Jan. 13, 2026
Jan. 07, 2026
Jan. 21, 2024
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Jun. 23, 2026
Apr. 30, 2026
Dec. 31, 2024
Equity [Line Items]                      
Gross cash proceeds           $ 1,598        
Shares issued           580,973   365,444      
Gross proceeds           $ 212 360        
Shareholders’ equity           11,271 (81) $ 5,147     $ 8,939
Non-controlling interests           7,326 $ 701 908      
January 2024 SEPA Agreement [Member]                      
Equity [Line Items]                      
Purchase sale         $ 20,000            
Commitment amount               $ 20,000      
Sale of ordinary shares               30,385      
Share price rate         97.00%            
Securities Purchase Agreements [Member]                      
Equity [Line Items]                      
Shares issued     85,131                
SEPA [Member]                      
Equity [Line Items]                      
Sale of ordinary shares   82,111                  
Gross proceeds   $ 832                  
SEPA [Member] | January 2024 SEPA Agreement [Member]                      
Equity [Line Items]                      
Gross proceeds               $ 6,255      
CliniQ Transaction [Member]                      
Equity [Line Items]                      
Shareholders’ equity           8,352          
Non-controlling interests           $ 6,501          
Pre-Funded Warrants [Member] | Xylo [Member]                      
Equity [Line Items]                      
Exercise price $ 0.009                    
Warrants and exercise 113,043                    
Ordinary Shares [Member]                      
Equity [Line Items]                      
Fully ordinary shares issued       32,816              
Ordinary shares granted discount rate       25.00%              
Shares issued               192      
Ordinary Shares [Member] | January 2026 Financing Round [Member]                      
Equity [Line Items]                      
Purchase price per share     $ 9                
Gross cash proceeds     $ 766                
Ordinary Shares [Member] | Pre-Funded Warrants [Member] | Xylo [Member]                      
Equity [Line Items]                      
Shares issued 113,043                    
Additional issuance of Ordinary Shares [Member]                      
Equity [Line Items]                      
Shares issued                 7,730 7,695